Colivet® solution, one of CEVA Animal Health’s range of 3 soluble antimicrobials for pigs has been renamed Coliscour®.
Phil McGuire, CEVA’s business unit manager, explains the reasoning behind the name change: “We simply felt that the easiest way to avoid confusion between our product and a totally different non-prescription product of a similar name was to give ours a new name that also reflects its use, hence Coliscour®.”
Francisco says he decided to launch the podcast after watching how the bond between society and veterinary professionals has been eroded in recent years, with vets increasingly being portrayed as money-grabbers and uncaring in the press.
The aim of the podcast is to show the human behind the surgical mask; that veterinary professionals have the same feelings, motivations, worries and passions as anyone else.
Francisco said: "For those who aren’t part of the veterinary community, I hope to open a window into who we are, so they can better understand what drives our behaviours, decisions and compassion. And for those who are, I hope to make them feel that they’re not alone."
More Than Just a Vet is open for everyone to listen to directly from the website morethanjustavet.net, where you can subscribe to be alerted when there's a new release. The podcast is also available on all major podcast providers.
Eggshell membrane is rich in proteins and contains collagen type I, hyaluronic acid, chondroitin sulphate and glucosamine. Virbac says the components of eggshell membrane help to limit inflammatory processes that occur in osteoarthritis and preserve the existing cartilage structure whilst promoting synthesis. The company points to a study which showed that eggshell membrane contributes to a reduction in pain perception by 25%, improved joint function by 33% and increased quality of life by 35% within 6 weeks1.
Rémi Mandray, Product Manager at Virbac said: "I am delighted to be able to introduce this innovative new ingredient to the Veterinary HPM Joint & Mobility Clinical Diet. This is an addition to an already very comprehensive approach to nutrition in dogs with osteoarthritis, which affects 20% of the adult canine population2. Studies have shown that improvement on mobility is visible as quickly as 2 weeks after diet introduction3 – changing their diet truly can change their life!’
For more information contact your Virbac Territory Manager.
Reference
The self-adhesive dressing, which uses a patented natural polymer, adapts to any part of the body and sets fast, acting as a waterproof barrier to the external environment which shields the site from unwanted moisture and bacterial ingress and allows the tissue underneath to repair in a protected environment.
It is proven to prevent the loss of therapeutic sprays when it is used as a barrier1.
The company says NoBACZ Bovine is easy to apply with a clean gloved hand and offers up to seven days’ protection without the need to reapply.
It is suitable for use on any site of the body, except the eyes, and has been especially widely used on hooves, horn buds and udders.
The liquid barrier dressing does not need to be removed as it will self-degrade and its ingredients dissolve naturally with no residue.
Dr Jonathan Powell, Director of Biomineral Research and Imaging at the University of Cambridge’s Department of Veterinary Medicine, and chief executive officer and co-founder of NoBACZ Healthcare, said: “Following several years of research at the University of Cambridge and comprehensive market analysis which identified an unmet need across the farming industry, we are absolutely delighted to launch NoBACZ Bovine, which offers unparalleled protection against harsh farm conditions, revolutionising wound protection in cattle and enhancing the health and welfare of the national herd.”
Mike Kerby, veterinary surgeon from Synergy Farm Health, who has used NoBACZ Bovine over many months, added: “I have been using NoBACZ Bovine for a while in cattle affected with UCD (udder cleft dermatitis) and DD (digital dermatitis) lesions as well as on wounds and granulomas.
"It is my clinical impression that it counters bacterial colonisation rapidly and promotes re-epithelialisation, which in turn helps to prevent the occurrence of proud flesh or reduces the mass of any existing granulomata.
"Application is simple and quick, with clients also finding it easy to reapply regularly within set treatment protocols.
"In addition to this, it was seen as a huge advantage that bandages and their removal are not involved, nor are antibiotics, making it labour saving, sustainable and eco-friendly.”
www.nobacz.com
Ceva says CLAS vials are proven to be easy to use, practical and eco-friendly and are preferred by 99% of farmers on farm1. They have 33% less impact on the environment from cradle to grave than glass2 and are robust and shock resistant3 for fewer breakages and losses. They are made from a lightweight material to make the vials easier to be transported and handled4 and have an ergonomic ‘grip groove’ for easier handing5.
Peter Keyte, ruminant business unit manager at Ceva Animal Health said: "Ceva’s CLAS vials are hugely popular with both vets and farmers due to their practicality, ease of use and environmental credentials.
“We are therefore delighted that Ketofen has joined the extensive range of livestock injectables available in CLAS.”
For further information contact your local Ceva territory manager, call Ceva on 01494 781510 or email cevauk@ceva.com.
References
The Action Plan presents what the College is doing to tackle the issue and explains how collaboration, culture change, career development and leadership, among other things, could help with workforce shortages by improving retention of current members of the professions, encouraging more people to join, and making it easier for those who have left the professions to return.
The report lists seven main areas to be addressed:
The full list of actions, with context about what has fed into ambitions, can be found in the Action Plan which is downloadable at www.rcvs.org.uk/publications.
Dr Sue Paterson FRCVS, Junior Vice-President and Chair of the RCVS Advancement of the Professions Committee, said: “This is a very complex, broad and multi-faceted area of concern so the Action Plan has been a long time in the making to ensure that we adequately capture what needs doing and how, in order to enable us to work collaboratively with all veterinary organisations going forward.
"This is not a finished list, but gives all within the veterinary sector the ability to look at the key areas of work that need to be done and prioritise the ones that most suit their organisational needs."
Merial has announced that a recent change of licence means you can now administer the new generation NSAID, Previcox® for the relief of post operative pain associated with soft tissue and orthopaedic surgery in dogs.
Mark Riggs MRCVS, Veterinary Technical Advisor for Merial said: "Previcox (firocoxib) is now licensed for the relief of post operative pain. Oral PREVICOX can be administered starting 2 hours prior to surgery and has a rapid onset of action reaching peak plasma levels within 90 minutes. The palatable tablet can be given without food and is a realistic option which should be seriously considered when choosing pain relief for surgical patients.
"Containing the active ingredient firocoxib, Previcox is also highly COX-2 selective, being 380 times more selective for COX-2 than COX-1. As a result, it offers a highly desirable efficacy and safety profile which is particularly beneficial in cases which have gone through the additional stress of surgery.
"The recently published study by John P. Punke et al strengthens the evidence reinforcing the benefits offered by firocoxib. The research evaluated the in-vivo effects of firocoxib, meloxicam and tepoxalin in target tissues of dogs suffering with chronic osteoarthritis.
"Eight dogs were used in the cross-over study and each dog received each of the treatments (and a placebo) for seven days, with an appropriate wash out period in between. Firocoxib significantly reduced inflammatory mediators within blood and synovial fluid at all time points, whereas meloxicam only showed a significant reduction compared to baseline values at day four.
"With evidence demonstrating the speed of the anti-inflammatory effect of firocoxib, it may be time for vets to reconsider their post operative pain management. Previcox can be administered orally prior to surgery and can be given once daily for up to three days post operatively. For orthopaedic surgery this treatment schedule can be extended after the first 3 days upon judgement of the attending vet."
For further information please contact your local territory manager or call the Merial Customer Support Centre on 0845 601 4236.
The webinar, titled: ‘When the coughing won’t stop…. what to do when standard BRD treatment protocols aren’t getting to the bottom of it’, aims help vets manage complex outbreaks that happen despite best practice management and treatment protocols.
The full programme includes:
The event is being held live so you can submit questions to the speakers, but the session will be recorded, so it can be watched again later.
Attendees will receive a certificate for one hour of CPD and the link to the recorded webinar.
To register, email the event team by 27 November 2020 at brdwebinar-group@ceva.com. In the email, please give your name and the email address to which you would like the registration link sent.
TVM says DogStem, which is currently the only UK/EU-licensed stem cell treatment for this condition, is clinically proven to reduce pain and lameness while improving mobility and quality of life for dogs over one year.
The training materials include downloadable teaching guides and two videos fronted by Dr Russell Chandler BVSc CertSAO MSc(OrthoEng) MRCVS, an Advanced Practitioner in Small Animal Orthopaedics (pictured).
The videos are designed to help GP vets become more confident about performing intra-articular injections in the hip and elbow, sharing principles and techniques which are also useful for performing arthrocentesis.
Specifically, the videos show the precise procedures, in both elbow and hip, for accessing joint spaces, confirming accurate placement by the appearance of synovial fluid and injecting DogStem.
The training guides offer supporting diagrams and explanations of the approaches to each joint.
Russell, who works at Alphavet Referrals in Newport, Gwent said: “We are proud to have been involved in the production of these training videos, which will support veterinary clinicians everywhere in providing pioneering stem cell treatment to improve the quality of life of dogs suffering from osteoarthritis.
“We have been using mesenchymal stem cell therapy for dogs with osteoarthritis, as part of a multimodal approach, for many years.
"The availability of an off-the-shelf stem cell product, namely DogStem, for the first time promises to greatly widen the applicability of stem cell therapy to these kinds of patients in veterinary practices.
“The early responses to treatment that we have seen with DogStem have been very encouraging.
"I look forward to following up these cases as they progress through their osteoarthritis journey.
"DogStem is simple to administer, once you have the skills to inject joints, and the support from the UK suppliers, TVM, has been excellent."
https://dogstem.co.uk/resources
Dechra says necrotic enteritis can be treated with a variety of therapeutic antibiotics but that the first choice antibiotics¹ for treatment are narrow spectrum antibiotics, like phenoxymethylpenicillin.
Phenocillin is an 800 mg/g powder for use in drinking water. It is lactose free, and Dechra says its high solubility makes it ideal for concentrated stock solutions and convenient for modern poultry farming. There is a zero withdrawal time so egg production is unaffected.
Dechra Brand Manager Emma Jennings said: “Necrotic enteritis is the most common bacterial disease in modern broiler flocks that can be financially devastating for farmers.
"The high concentration means easy dosage and handling with less waste and the lactose free formula reduces the risk of biofilm development resulting in a high quality and effective product, supporting the responsible use of antimicrobials.
"Phenocillin is a highly effective treatment and we anticipate it will become the preferred solution for veterinary professionals and end users to treat this disease that can very suddenly devastate broiler flocks."
For more information, visit: http://bit.ly/2nAboGU
Backed by RJD Partners, the directors bought the company back from Benchmark Plc for a reported £12.75M after it decided to divest itself of all non-aquaculture-related assets.
Improve says that under its new leadership, it plans to expand its e-learning portfolio significantly, harnessing technologies like video teaching and virtual/augmented reality to offer a richer learning experience.
The company will continue to offer attended modular training options as well as small group practical teaching sessions at its wet labs in Swindon and Sheffield. It says these events will complement its online programmes and will provide stand-alone training for vets wishing to learn new surgical and diagnostic skills.
In collaboration with its assessment partner, the International School of Veterinary Postgraduate Studies (ISVPS), Improve will be developing new distance-learning programmes, together with exams that can be taken remotely.
Improve also plans further geographical expansion, including running programmes in languages including French, Spanish, German and Chinese.
Dr Heber Alves (pictured right) is Improve’s new CEO. He is supported by a management team that includes Improve founder Dr David Babington, Business Development Director and Mr John Douglass, UK Managing Director.
Heber said: “Improve is fully owned by a team of experienced veterinary and business professionals with a unique understanding of the profession’s training needs at a global level. Even better, we are backed by a private equity partner with a strong track record in professional education and a commitment to supporting our growth, both organically and through acquisition.
“We start this new chapter in a world changed irrevocably by COVID-19. It is a world in which veterinary professionals are demanding more flexible ways of learning and showing a hunger to achieve additional qualifications. With this in mind, we will be working to offer a combination of high quality practical, remote and blended learning that will make the achievement of a postgraduate qualification a realistic ambition for every vet."
Elanco Animal Health is reminding vets about the importance of correctly interpreting oocyst counts in the diagnosis of coccidiosis during the post lambing period.
The company says scouring lambs that are failing to thrive should immediately ring the alarm bells for coccidiosis. Typically, oocyst counts of >20,000 per gram are cited as diagnostic for coccidiosis in sheep, but counts of up to 100,000 oocysts per gram have been reported in apparently healthy lambs and disease can also occur in the presence of low or negligible counts where there is gut damage but before oocysts have been shed.1 These discrepancies can lead to misdiagnosis and as such, oocyst counts should always be interpreted with care.
Oocysts of the fourteen Eimeria species described as specific to sheep are indistinguishable from each other by eye and only two species - E. ovinoidalis and E. crandallis, are actually pathogenic.1 For this reason, diagnosing coccidiosis based on clinical signs of diarrhoea and oocysts in their faeces alone can generate false positives. This could lead to important differentials, such as Nematodirus battus infection (for lambs at pasture) being left untreated.
According to the company, false negatives are also a concern, particularly as prompt treatment of clinical cases with an anti-coccidial, such as diclazuril (Vexocan® 2.5mg/ml oral suspension) has been proven to reduce the convalescence period.2 Shedding of oocysts varies with disease progression and faecal counts can fluctuate significantly.3 For example, a delay between the development of clinical signs and oocysts appearing in faeces is common. Another possibility is sub-clinical disease, with affected lambs showing no typical outward signs. The gut damage caused by the parasite can be significant in these animals though, adversely affecting growth rates.
Elanco says that for reliable diagnosis of coccidiosis, faecal oocyst counts should be considered alongside disease and farm history, followed with Eimeria species identification if possible. The disease typically affects groups of lambs aged between 3-8 weeks old and is often triggered by a stressor such as castration, weaning, turnout and/or bad weather. If clinical signs appear around three weeks after such an event, the suspicion of coccidiosis can be heightened. For some farms, predictable stressors cause disease outbreaks year after year and in these cases, a metaphylactic dose of Vecoxan® can be administered to susceptible lambs 14 days after the trigger event.
Finally, the company says veterinary surgeons should also not forget the importance of good management when advising farmers about coccidiosis control. Lambing pen and high traffic area hygiene and age batching lambs are essential for long term control.
The new distribution service uses Invatech's Patient Medication Record (PMR) system, called Titan, which was accredited by the NHS a little over a year ago. Titan has now been developed further to support the company's Home Pharmacy service, and integrate with MWI.
The company says the new system offers practices a seamless workflow between prescribing, dispensing and logistics systems.
Tariq Muhammad, CEO of Invatech Health, said: "“The use of PMR systems for the veterinary market has been very light touch until now. Knowing that that we can bring the same level of efficiency and workflow to a new market presents an opportunity to support animal health in the same way that we do for human health."
Alan White, Commercial Director at MWI Animal Health, said: “The Covid pandemic has presented many challenges to veterinary professionals in the UK. Travel restrictions and social distancing measures make it difficult for animal owners to collect the medications and treatments they need from veterinary practices.”
“We are excited to be able to work with Invatech to provide an innovative solution to this problem, where vets can send the medications needed directly to their client. Working in partnership with veterinary practices and Invatech means we can move animal health forward together.”
For more information, visit: https://www.invatechhealth.com/
The first is the introduction of Specialist training and status for general practitioners in primary care, for which the RCVS project will now develop a new five-year curriculum and an implementation plan.
The RCVS will also be looking closer at the definition of veterinary clinical roles and developing guidance for the profession and wider public on the different clinical career statuses available to veterinary surgeons.
Thirdly, the College will identify different ways in which vets can access the teaching and learning opportunities, clinical experience/cases, supervision and support that is required for them to complete specialist training and obtain RCVS Specialist status.
This will include looking at how access to specialist training can be widened beyond the typical internship/residency model, to include training models more accessible from primary care practice, and for those at different career and life stages.
Kate Richards MRCVS, Chair of the RCVS Education Committee, said: “These exciting and progressive proposals are visionary as far as the career and development structure of the veterinary clinical profession is concerned.
“It means there will be new prospects for those in general practice and those who want to achieve Specialist status by different means, as well as a more defined career structure for the profession that will be clearer to the profession and general public alike.
"With around 75-80% of veterinary professionals working in clinical practice this project will deliver a substantial positive impact.
“These are the early pages of a very exciting new chapter for veterinary clinical careers, and we will be asking for your help to write it, as we will be holding a number of consultations in the coming years, including on the programme for Specialist in Primary Care and the definition of clinical roles.
RCVS President Dr Sue Paterson FRCVS added: “There are two aspects of the project that I particularly welcome.
"First is the impact this could have on both recruitment and retention as vets are offered additional, and more diversified, career options and expanded roles in a variety of clinical settings.
"Second, as a specialist dermatologist myself, I really value the fact that we will be looking at ways to widen participation and increase accessibility to specialist training from primary care practice, as the residency/internship route is very intensive and not necessarily suitable for everyone.
A similar process to develop and enhance clinical career pathways for veterinary nurses is now also being considered, this would include the development of an ‘Advanced Veterinary Nurse’ status and clearer information on the veterinary nursing role and what it entails.
Mandisa qualified from the Royal (Dick) Vet School in Edinburgh in 2008 and has since spent much of her career working in emergency and critical care.
She served as the first black president of the RCVS in 2020/21 and has also worked for Harper Adams University as a lecturer in veterinary sciences.
Mandisa will replace Laura Playforth, who is joining IVC Evidensia as group QI director, on the Vets Now board.
She said: “I’m delighted to be joining the Vets Now family at such an interesting and challenging time for the veterinary professions.
“I look forward to working together through innovative approaches to ensure our teams continue to deliver the highest standards of clinical care and client services.”
The RSPCA reports that it has saved nearly 400 animals from flooding, including 40 fish, in the last 3 days alone.
The koi carp were rescued from a pond in Wraysbury, Berkshire, which was being overcome by rising floodwater.
Other rescues have included:
The charity says its flood rescue team has helped 586 animals affected by floods since Jan, with 386 of those in the last three days alone. Their efforts were praised by Labour leader Ed Milliband yesterday, who was at the scene with an RSPCA water rescue team in Wraysbury.
RSPCA flood rescue co-ordinator Jason Finch said: "The water rescue teams on the ground are doing an amazing job with limited resources. We will continue to do everything we can to help animals, and humans, during this difficult time and are so grateful for all the support our workers have received from the public."
Photograph courtesy RSPCA
CEVA Animal Health has launched Diarsanyl Plus, a new intestinal support paste for dogs, cats and small animals containing prebiotics.
Diarsanyl Plus contains the same unique combination of ingredients as Diarsanyl - montmorillonite, Na+, Mg2+ and K+ ions and dextrose - but now also contains prebiotics called fructo-oligosaccharides (FOS).
According to the company, montmorillonite maintains intestinal function by coating and protecting the enterocytes and absorbing toxins, Na+, Mg2+ and K+ ions help maintain electrolyte levels and dextrose provides a much needed energy source for the small intestine. The prebiotics help maintain normal intestinal flora by promoting the growth of good bacteria such as bifidobacteria and lactobacilli and stimulating the production of short chain fatty acids (SCFAs) - acetate, propionate and butyrate - which are important energy sources for the large intestine.
Fraser Broadfoot, product manager at CEVA Animal Health said: "Diarsanyl Plus will build on the proven efficacy of Diarsanyl by including prebiotics that naturally balance the intestinal flora of animals with digestive upsets and diarrhoea. The new easy-to-use syringes and palatable formulation will also make it easier for pet owners to administer."
Diarsanyl Plus is available in 10ml, 24ml and 60ml pack sizes for a variety of species, from small animals to large dogs.
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
Merial is offering four free tubes of Eqvalan Duo to practices that buy 20 tubes in February and March. In addition, to further boost the targeted worming message, Merial will supply 20 free worm egg count vouchers worth £10 each.
Eqvalan Product Manager Claire Edmunds said: "Last year's campaign was so well received by both practices and clients that we have decided to run it again and are hoping for even better results!
"The personalised online planner, worm egg count offer and new eye-catching point of sale all help you to engage your clients in a targeted worming strategy.
For those practices with their own, in-house worm egg count testing facilities, Merial is also offering promotional support to help encourage increased uptake and client buy-in. The campaign forms part of Merial's promotion and education strategy for 2011, which includes extensive VN SQP CPD training opportunities.
To find out more contact your local Area Manager or call the Merial Customer Support Centre on 0845 601 4236
The College has confirmed that it has now received an official complaint about the matter and it is now investigating under its normal 'concerns' investigation process.
Professor Argyle made a private statement about the allegations to RCVS Council at its meeting today, having already answered written questions from a number of Council members in the preceding days.
The Council did not ask Professor Argyle to step aside, but acknowledged that this was his choice, made for personal reasons.
The College said that in line with its normal protocols, and to ensure fairness for all parties, it will not make any further public comment about the investigation for the time being. However, it wanted to stress that it remains firmly committed to following due and proper process in all its regulatory activities.
The Royal Veterinary College has announced the appointment of Professor Stuart Reid as its new Principal and the successor to Professor Quintin McKellar.
Professor Reid BVMS, PhD, DVM, DipECVPH, FRSE, MRCVS, joins the RVC from the University of Glasgow, where he was Professor of Veterinary Informatics and Epidemiology and Head of the School of Veterinary Medicine. He will take up his new role on 1st January 2011.
Professor Reid began his career in 1987 as an Assistant Veterinary Surgeon before joining the University of Glasgow as a Clinical Research Scholar in 1988. In 1992 he assumed the role of Post Doctoral Research Fellow at the University and was promoted to Senior Post-Doctoral Research Fellow in 1994. He was appointed to the first joint Chair between the Universities of Strathclyde and Glasgow in 1997, as Professor of Veterinary Informatics and Epidemiology. In 2004 he became Associate Dean of Research and, in 2005, he became Dean of the Faculty of Veterinary Medicine at the University of Glasgow.
"I am delighted and honoured to be joining the Royal Veterinary College at this important time." said Professor Reid. "The RVC has an enviable heritage and is a world leader in terms of its innovation and leadership in veterinary education, research and clinical service. I recognise that I am enormously privileged to be moving from a great School to a great College and I look forward to building on the successes achieved by RVC under Principal McKellar at the same time as rising to the challenges of a new funding environment."
Professor Quintin McKellar was appointed Principal in August 2004. He leaves the RVC to take the post of Vice-Chancellor of the University of Hertfordshire.
Chairman of the RVC Council, The Right Hon the Baroness Shephard of Northwold, said: "Great strides have been made under Professor McKellar's dynamic leadership, and I am sure I speak for all at the College when I say we will be sad to see him go. We look forward to welcoming Professor Stuart Reid, and firmly believe that his experience and distinguished academic record will assist the Royal Veterinary College in strengthening its position over the coming years."
The BSAVA reports that two four month old puppies in The Netherlands have tested positive for rabies.
The puppies were imported into The Netherlands from Bulgaria on October 5th. Reports indicate that these puppies, which were both microchipped and travelling under the Pet Passport scheme, originated from a shelter in Bulgaria. They are still trying to trace the driver and passenger who delivered the puppies.
One puppy started showing signs of fever and paralysis on 10th October and was euthanased on 18th October, it has tested positive for rabies on both direct immunofluorescence (DIF) and polymerase chain reaction (PCR).
The second puppy was euthanased because it originated from the same litter, although it was living in a different area of the country by this time. This dog was suffering from haemorrhagic gastro-enteritis (HGE), but showed no neurological signs. However it has also tested positive for rabies on both DIF and PCR.
The BSAVA says this aspect of the case will be of particular concern to veterinary professionals in the UK because HGE is commonly seen in unvaccinated (imported) puppies. Preliminary reports do not make clear the vaccination status of these dogs.
BSAVA President, Professor Michael Day, said: "Not only does this demonstrate the need for pet owners to comply with pet travel legislation, but also for vets to be alert to the possibility of disease with any imported animal.
"Whilst we have been concerned about the issue of illegal imports and the enforcement of the current legislation, this latest incident also raises the possibility of rabies cases in dogs that appear to comply with the current pet passport regulation."
This calls into question whether veterinary staff in first opinion practice should be offered the pre-exposure rabies vaccination. The current recommendations from Public Health England are that all individuals at continuous and frequent risk of exposure to the rabies virus, as well as some groups at infrequent risk, should be offered pre-exposure rabies vaccination. Professor Day said: "Whilst veterinary professionals in companion animal practice are not currently included in this list, this might be a timely point to undertake a review based on a new risk assessment. I would be in support of practitioners who believe they are at risk having the option of the subsidised occupational vaccination."
UK veterinary surgeons are reminded that responsibility for dealing with illegal imports rests with local authorities; usually Trading Standards or Environmental Health. However, if a veterinary surgeon in practice has any suspicion of rabies or any other notifiable disease they should inform their local Animal Health Office.
Vet Direct says the unit, which is used for the diagnosis and monitoring of anaemia in dogs, cats and horses, requires only a simple ear-prick test to deliver a result.
Leon Wright, managing director at Vet Direct, said: "The AniPoc device eliminates the need to draw blood with a syringe, a simple pin prick is enough, and is perfect for both veterinary practices and home visits.
"The speed and accuracy of the product means that it is better equipped to monitor animals undergoing anaesthesia or transfusions, and can be used to effectively screen animals taking part in Pet Blood Banks and mobile clinics."
Vet Direct says the AniPoc also delivers results much faster than a centrifuge and doesn’t require any time to be spent in the lab; a process which can take 10-20 minutes to get a result - by which time they are often out-of-date in critical cases.
The AniPoc Handheld Monitor and Starter Kit is available from Vet Direct for £250.
For more information, visit www.vet-direct.com or call 0800 068 3300.
Rodolfo said: “We are the only independent specialist veterinary hospital in the area with the equipment and experience to diagnose and manage neurological issues in pets.
"With a custom-built veterinary hospital and the expertise to help vets get the best results for their patients, we will provide the next level of affordable, specialist care for owners and their pets with the transparency that our independent status enables.
“We will work hand in hand with referring vets, consulting with them on the best approach for their clients and always keep them fully updated on progress as each case unfolds.
"Initially, we are offering neurology services, but we plan to quickly upscale our operations and offer other services like orthopaedics soon.”
Pets suffering from symptoms including seizures, pain, difficulty walking and problems with balance and orientation can be referred.
"Any peripheral nervous system problems and neuromuscular diseases outside the spinal cord area can also be identified and treated.
Rodolfo added: “My focus is on pure collaboration with the vets that refer to us and their owners.
"I’m wholeheartedly motivated by providing the very best service at accessible prices.
"With a focus on communication and compassion – we will always work with the first opinion vet to put the best interests of their clients’ pets first.
www.southeastvetreferrals.com
CVS has announced its acquisition of the West End Veterinary Partnership, an Edinburgh-based veterinary practice, bringing the number of practice groups owned by the company to 100, operating out of 267 sites across the UK.
West End Vets employs around 12 staff. Its main site is in Bread Street and it has two branches elsewhere in the city. Owners David Rimer and Maurice Hunter are joining CVS as joint Clinical Directors.
Simon Innes, CVS Chief Executive, said: "We are rapidly broadening the range of practices within CVS, both in terms of the type of practice and in terms of geographic spread. West End Vets is a successful and popular practice in Edinburgh and we are delighted that it has now joined our family."
Founded in 1999 and run principally by vets, CVS employs more than 3,000 staff at its practices and surgeries across the UK and in its related veterinary businesses, including an online pharmacy, three pet crematoriums and five veterinary laboratories.
At the heart of the campaign is a website - www.beatdogheartdisease.co.uk - where dog owners can learn more about mitral valve disease and dilated cardiomyopathy, find out which breeds are most at risk and read more about the diagnosis and management of canine heart disease.
Boehringer has also created a Facebook page - www.facebook.com/beatcanineheartdisease - offering regular updates on heart health and a platform for owners to share their stories. Owners can also use the ‘Love Your Dog’s Heart’ Facebook profile frame to help spread awareness of the disease.
The aim of the campaign is to get pet owners thinking about mitral valve disease and having it treated whilst it is still in the asymptomatic phase, in order to slow the disease progression and delay the onset of heart failure1.
Vetmedin practices can access additional ‘Love Your Dog’s Heart’ campaign materials via the Boehringer Ingelheim Resource Hub at boehringer-ingelheim-resourcehub.co.uk.